UK markets close in 3 hours 20 minutes

Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA)

São Paulo - São Paulo Delayed price. Currency in BRL
Add to watchlist
5.80+0.13 (+2.29%)
At close: 05:07PM BRT
Currency in BRL

Valuation measures4

Market cap (intra-day) 2.95B
Enterprise value 7.31B
Trailing P/E 15.05
Forward P/E 17.54
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.56
Price/book (mrq)1.28
Enterprise value/revenue 1.29
Enterprise value/EBITDA 7.02

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3-38.30%
S&P500 52-week change 326.24%
52-week high 313.00
52-week low 30.00
50-day moving average 37.27
200-day moving average 39.82

Share statistics

Avg vol (3-month) 36.11M
Avg vol (10-day) 34.89M
Shares outstanding 5508.29M
Implied shares outstanding 6508.29M
Float 8489.35M
% held by insiders 12.95%
% held by institutions 168.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.73%
Operating margin (ttm)11.44%

Management effectiveness

Return on assets (ttm)5.05%
Return on equity (ttm)11.14%

Income statement

Revenue (ttm)5.65B
Revenue per share (ttm)10.64
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)N/A
EBITDA 892M
Net income avi to common (ttm)211.03M
Diluted EPS (ttm)0.39
Quarterly earnings growth (yoy)-56.80%

Balance sheet

Total cash (mrq)412.77M
Total cash per share (mrq)0.81
Total debt (mrq)4.77B
Total debt/equity (mrq)178.47%
Current ratio (mrq)1.28
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)62.13M
Levered free cash flow (ttm)-201.34M